Australia markets open in 6 hours 56 minutes

Paradigm Biopharmaceuticals Limited (PAR.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.28500.0000 (0.00%)
At close: 04:10PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
46.76
46.76
79.224
20.55
-
Cost of revenue
18.827
18.827
143.751
99.138
-
Gross profit
27.933
27.933
-64.527
-78.588
-
Operating expenses
Research development
52,679
52,679
39,012
33,517
12,794
Selling general and administrative
6,565
6,565
7,934
8,748
4,167
Total operating expenses
60,066
60,066
47,926
43,312
17,173
Operating income or loss
-60,039
-60,039
-47,991
-43,391
-17,173
Interest expense
16.416
16.416
28.633
37.722
34.168
Total other income/expenses net
6,742
6,742
8,657
8,712
3,698
Income before tax
-51,910
-51,910
-39,250
-34,297
-12,299
Income tax expense
0
0
0
0
0
Income from continuing operations
-51,910
-51,910
-39,250
-34,297
-12,299
Net income
-51,910
-51,910
-39,250
-34,297
-12,299
Net income available to common shareholders
-51,910
-51,910
-39,250
-34,297
-12,299
Basic EPS
-0.18
-0.18
-0.16
-0.16
-0.06
Diluted EPS
-0.18
-0.18
-0.16
-0.16
-0.06
Basic average shares
289,678
289,678
240,964
212,192
208,266
Diluted average shares
289,678
289,678
240,964
212,192
208,266